Various studies reported that resveratrol stimulated proliferation of ERα+ breast cancer cells at low doses (<10–22 μM) but inhibited proliferation and induced cell death at higher doses (>10–22 μM) [185,186,187,188,189]. Here, ESR1 is linked to breast carcinoma.